Gujarat Themis Biosyn (NSE:GUJTHEM) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GUJTHEM Gujarat Themis Biosyn Ltd NSE:GUJTHEM
64 GF Score
Price ₹363.95
GF Value ₹312.84
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Gujarat Themis Biosyn Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:GUJTHEM vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Themis Biosyn's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gujarat Themis Biosyn Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Themis Biosyn's Short Interest distribution charts can be found below:

* The bar in red indicates where Gujarat Themis Biosyn's Short Interest falls into.


NSE:GUJTHEM
64GF Score
Gujarat Themis Biosyn Ltd NSE:GUJTHEM
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gujarat Themis Biosyn (NSE:GUJTHEM) Overvalued in 2026?

Based on GuruFocus' analysis, Gujarat Themis Biosyn stock appears to be overvalued. The current stock price of ₹363.95 is trading 16.3% above its estimated GF Value™ of ₹312.84. GuruFocus considers Gujarat Themis Biosyn to be Modestly Overvalued.

Key valuation signals for NSE:GUJTHEM:

  • Short Interest:
  • GF Value™: ₹312.84 vs. price of ₹363.95 (16.3% above fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the NSE:GUJTHEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gujarat Themis Biosyn Business Description

Other Exchanges 506879:India
Address S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
64GF Score

Get the complete analysis for NSE:GUJTHEM

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹363.95
Price
₹312.84
GF Value